Latest news for AMERISAFE (NASDAQ:AMSF) Stock

AMERISAFE

AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.

Earnings

Earnings Misses

News

Small Cap

Markets

Analyst Ratings

Trading Ideas

AMSF

KNSL

AMERISAFE, Inc.&#39;s (NASDAQ: AMSF) shares have lost 5.3% since it reported second-quarter 2024 results on Jul 29. Investors may have been worried about weakness in underwriting results inducing a deterioration in the net combined ratio.

AMERISAFE Stock Down 5.3% Since Q2 Earnings Miss

Penny Stocks

Short Ideas

Pre-Market Outlook

CTLP

LMND

OPRT

The most overbought stocks in the financial sector presents an opportunity to go short on these overvalued companies.

Top 5 Financial Stocks That Could Sink Your Portfolio This Quarter

Image via Shutterstock

Social Media

Tech

General

TSLA

Tesla, Meta, Helix Energy, AMERISAFE, Forum Energy Technologies: Why These 5 Stocks Are Drawing Investors&#39; Attention Today

AMERISAFE Inc

AMERISAFE, Inc.&#39;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsf#NASDAQ">AMSF</a>) shares have lost 5.3% since it reported second-quarter 2024 results on Jul 29. Investors may have been worried about weakness in underwriting results inducing a deterioration in the net combined ratio. An elevated operating expense level, resulting from an increase in loss and loss adjustment expenses incurred, underwriting and other operating costs and policyholder dividends, also contributed to the downside. Improved audit premiums partially offset the negatives.
AMSF reported second-quarter adjusted earnings per share of 58 cents, which missed the Zacks Consensus Estimate by 4.9%. Moreover, the bottom line dipped 20.5% year over year.
Operating revenues improved 3.4% year over year to $76 million. The top line beat the consensus mark by 2.4%.
<div class="chart_embed">
<h3>AMERISAFE, Inc. Price, Consensus and EPS Surprise</h3>
<img alt="AMERISAFE, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/32/1722871229.png" style="height:265px; width:620px" title="" />
AMERISAFE, Inc. price-consensus-eps-surprise-chart | AMERISAFE, Inc. Quote
</div>
<h3>Q2 Performance</h3>
Net premiums earned of $68.6 million improved 4.6% year over year in the quarter under review and outpaced the Zacks Consensus Estimate of $66 million. The metric benefited from improved contributions from payroll audits and related premium adjustments as a result of persistent payroll strength.
Net investment income dipped 3.6% year over year to $7.4 million due to a reduced portfolio size. However, this was partially offset by improved reinvestment rates. The metric fell short of the consensus mark of $7.8 million. Fee and other losses were $75 million.
AMERISAFE reported a pre-tax underwriting profit of $6.5 million, which declined 31.2% year over year.
Total expenses escalated 10.7% year over year to $62.1 million in the second quarter.
Operating net income of $11.1 million decreased 20.2% year over year.
The net combined ratio deteriorated 510 basis points (bps) year over year to 90.5% and came higher than the consensus mark of 90%. The metric suffered due to a deteriorating net loss ratio.
<h3>Financial Update (as of Jun 30, 2024)</h3>
AMERISAFE exited the second quarter with cash and cash equivalents of $30.6 million, which declined 20.9% from the 2023-end level.
Total assets of $1.2 billion increased 0.4% from the figure in 2023-end.
Shareholders&#39; equity of $301 million grew 2.9% from the 2023-end level.
Book value per share was $15.78 as of Jun 30, 2024, which improved 3.3% from the 2023-end figure.
Return on average equity deteriorated 400 bps year over year to 14.6% in the quarter under review.
<h3>Dividend Update</h3>
Management announced a quarterly cash dividend of 37 cents per share, which will be paid out on Sep 20, 2024, to its shareholders of record as of Sep 6.
<h3>Zacks Rank</h3>
AMERISAFE currently carries a Zacks Rank #4 (Sell).
<h3>Performances of Other Insurers</h3>
Of the insurance industry players that have reported second-quarter 2024 results so far, the bottom-line results of&nbsp;Marsh &amp; McLennan Companies, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mmc#NYSE">MMC</a>),&nbsp;Brown &amp; Brown, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bro#NYSE">BRO</a>) and&nbsp;Kinsale Capital Group, Inc.&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/knsl#NYSE">KNSL</a>) beat the Zacks Consensus Estimate.
Marsh &amp; McLennan reported second-quarter 2024 adjusted earnings per share of $2.41, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 10% year over year.&nbsp; Consolidated revenues rose 6% year over year to $6.2 billion. The figure also improved 6% on an underlying basis.&nbsp; The top line, however, fell short of the consensus mark by 1%. MMC&#39;s adjusted operating income was $1.72 billion, which grew 11% year over year. Adjusted operating margin improved 130 bps year over year to 29%.
The Risk and Insurance Services segment&#39;s revenues were $4.02 billion, which advanced 8% year over year and 7% on an underlying basis. Adjusted operating income advanced 12% year over year to $1.34 billion. Revenues of Marsh, a unit within the segment, improved 8% year over year and 7% on an underlying basis to $3.27 billion. In the United States/Canada, underlying revenues grew 6% year over year. International operations also witnessed underlying revenue growth of 7%. &nbsp;
Brown &amp; Brown&#39;s second-quarter adjusted earnings of 93 cents per share beat the Zacks Consensus Estimate by 6.8%. The bottom line increased 17.7% year over year. Total revenues of $1.2 billion beat the consensus estimate by 3.3%. The top line improved 12.5% year over year. The upside can be primarily attributed to commission and fees, which grew 11.4% year over year to $1.1 billion.&nbsp;
Organic revenues improved 10% to $1 billion. Investment income more than doubled year over year to $22 million. Adjusted EBITDAC was $420 million, up 17.3% year over year. EBITDAC margin expanded 150 bps year over year to 35.7%.&nbsp;
Kinsale Capital delivered second-quarter net operating earnings of $3.75 per share, which outpaced the Zacks Consensus Estimate by 6.5%. The bottom line increased 30.4% year over year.&nbsp; Operating revenues jumped 45.1% year over year to $378 million. Revenues beat the consensus estimate of $377 million. Gross written premiums of $529.8 million rose 20.9% year over year. Net written premiums climbed 17.9% year over year to $430.2 million.&nbsp;
Net investment income increased 48.3% year over year to $35.8 million. Kinsale Capital&#39;s underwriting income was $76.1 million, which grew 23.6% year over year. The combined ratio deteriorated 100 bps to 77.7% in the quarter under review. The expense ratio deteriorated 10 bps to 21.1, while the loss ratio deteriorated 60 bps to 56.6.
<a href="https://www.zacks.com/stock/news/2316354/amerisafe-amsf-stock-down-5-3-since-q2-earnings-miss?cid=CS-BENZ-FT-analyst_blog|earnings_article-2316354">To read this article on Zacks.com click here.</a>

JMP Securities analyst Matthew Carletti reiterates AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) with a Market Outperform and maintains $65 price target.

Price Target

Reiteration

JMP Securities Reiterates Market Outperform on AMERISAFE, Maintains $65 Price Target

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.63 by 9.52 percent. This is a 21.92 percent decrease over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $75.83 million which beat the analyst consensus estimate of $74.19 million by 2.20 percent. This is a 0.23 percent increase over sales of $75.66 million the same period last year.

Earnings Beats

AMERISAFE Q2 Adj $0.57 Misses $0.63 Estimate, Sales $75.83M Beat $74.19M Estimate

WIIM

AMERISAFE shares are trading lower after the company reported Q1 financial results.

AMERISAFE Q1 Operating Income Per Share $0.69

Dividends

AMERISAFE Increases Quarterly Dividend From $0.34 To $0.37/Share

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
AMERISAFE beat estimated earnings by 4.23%, reporting an EPS of $0.74 versus an estimate of $0.71.
Revenue was up $355 thousand from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.08 which was followed by a 2.77% drop in the share price the next day.
Here's a look at AMERISAFE's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.69</td>
<td>0.72</td>
<td>0.72</td>
<td>0.77</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.61</td>
<td>0.73</td>
<td>0.83</td>
<td>0.84</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>74.44M</td>
<td>76.20M</td>
<td>74.53M</td>
<td>75.06M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>72.64M</td>
<td>75.66M</td>
<td>78.44M</td>
<td>79.76M</td>
</tr>
</tbody>
</table>

To track all earnings releases for AMERISAFE <a href="https://www.benzinga.com/quote/AMSF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMERISAFE: Q4 Earnings Insights

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) reported quarterly earnings of $0.74 per share which beat the analyst consensus estimate of $0.71 by 4.23 percent. The company reported quarterly sales of $80.12 million which beat the analyst consensus estimate of $75.15 million by 6.61 percent. This is a 0.45 percent increase over sales of $79.76 million the same period last year.

AMERISAFE Q4 2023 Adj EPS $0.74 Beats $0.71 Estimate, Sales $80.12M Beat $75.15M Estimate

ACVA

ALIT

ANSS

ATNI

BALY

BELFA

BELFB

BLCO

BRDG

BROS

BRSP

CAKE

CCAP

CCRN

CCSI

CENX

CHDN

CHRD

CNNE

COKE

CSTE

CSTM

DINO

DOCN

ECPG

ERII

ESEA

ETSY

EXAS

FIVN

GATO

GKOS

GLBE

GOOD

GRMN

GSHD

ICLR

INSG

IONS

JACK

JOBY

KALU

LANV

LCID

LIVN

LUNG

MATV

MGRC

MTLS

NDSN

NEXA

NGVT

NOVA

NVDA

NVRO

NYMT

OBDC

Earnings Scheduled For February 21, 2024

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-02-21. Here's what investors need to know before the announcement.
Analysts estimate that AMERISAFE will report an earnings per share (EPS) of $0.71. 
AMERISAFE bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.08, which was followed by a 2.77% drop in the share price the next day.
Here's a look at AMERISAFE's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.69</td>
<td>0.72</td>
<td>0.72</td>
<td>0.77</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.61</td>
<td>0.73</td>
<td>0.83</td>
<td>0.84</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.77%</td>
<td>-5.24%</td>
<td>3.97%</td>
<td>-2.07%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1708441327_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of AMERISAFE were trading at $50.25 as of February 19. Over the last 52-week period, shares are down 8.12%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/AMSF/earnings">To track all earnings releases for AMERISAFE visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For AMERISAFE

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. 
<h3>Gainers</h3>
<ul>
<li>Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) stock rose 2.38% to $82.5 during Wednesday's regular session. Trading volume for Arch Capital Group's stock is 801.6K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $30.1 billion. </li>
<li>American Coastal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) shares rose 2.32% to $11.89. As of 12:40 EST, this security is trading at a volume of 113.4K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $510.0 million. </li>
<li>AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) shares moved upwards by 2.09% to $50.25. As of 12:40 EST, this security is trading at a volume of 91.8K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $944.1 million. </li>
<li>Hamilton Insurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HG#NYSE">HG</a>) stock increased by 1.76% to $14.97. The current volume of 22.1K shares is 0% of Hamilton Insurance Group's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at $1.6 billion. </li>
<li>Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) stock increased by 1.38% to $385.0. The current volume of 118.4K shares is 0% of Everest Group's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $16.4 billion. </li>
<li>Brighthouse Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHFAP#NASDAQ">BHFAP</a>) stock rose 1.22% to $24.71. The current volume of 22.8K shares is 0% of Brighthouse Finl's average full-day volume over the last 100 days (last updated at 12:40 EST). </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) shares declined by 4.46% to $11.58 during Wednesday's regular session. As of 12:40 EST, this security is trading at a volume of 1.8K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at 566109838. </li>
<li>Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) shares fell 4.35% to $1.32. Trading volume for Marpai's stock is 30.2K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.7 million. </li>
<li>Fanhua (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANH#NASDAQ">FANH</a>) shares fell 3.07% to $6.01. Trading volume for Fanhua's stock is 4.2K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $360.2 million. </li>
<li>Root (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) stock decreased by 2.86% to $8.18. As of 12:40 EST, this security is trading at a volume of 27.0K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $126.2 million. </li>
<li>Maiden Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHLD#NASDAQ">MHLD</a>) shares decreased by 2.83% to $1.72. Trading volume for this security as of 12:40 EST is 14.8K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $177.6 million. </li>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) shares decreased by 2.65% to $12.13. Trading volume for this security as of 12:40 EST is 15.0K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at 593002500. </li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ACGL

ACIC

BHFAP

FANH

MHLD

MRAI

ROOT

Insurance Stocks Moving In Wednesday's Intraday Session

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. 
<h3>Gainers</h3>
<ul>
<li>Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) stock rose 11.79% to $232.24 during Thursday's regular session. As of 13:40 EST, this security is trading at a volume of 804.6K shares, making up 119.9% of its average full-day volume over the last 100 days. The company's market cap stands at $23.0 billion. As per the news, the Q3 earnings report came out today. </li>
<li>Stewart Information Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STC#NYSE">STC</a>) stock moved upwards by 7.12% to $41.79. Trading volume for this security as of 13:40 EST is 179.7K, which is 107.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Global Indemnity Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBLI#NYSE">GBLI</a>) stock rose 5.03% to $36.76. As of 13:40 EST, this security is trading at a volume of 312 shares, making up 9.4% of its average full-day volume over the last 100 days. The company's market cap stands at $476.6 million. </li>
<li>Old Republic Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORI#NYSE">ORI</a>) shares rose 4.19% to $27.95. The current volume of 1.0 million shares is 65.2% of Old Republic Intl's average full-day volume over the last 100 days (last updated at 13:40 EST). The company's market cap stands at $7.6 billion. The company's, Q3 earnings came out today. </li>
<li>First American Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FAF#NYSE">FAF</a>) stock increased by 4.14% to $52.13. As of 13:40 EST, First American Financial's stock is trading at a volume of 712.0K, which is 143.1% of its average full-day volume over the last 100 days. The company's market cap stands at $5.1 billion. As per the press release, Q3 earnings came out today. </li>
<li>Fidelity National Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNF#NYSE">FNF</a>) shares increased by 3.15% to $38.55. Fidelity National Finl's stock is trading at a volume of 1.0 million shares as of 13:40 EST. This is 48.4% of its average full-day volume over the last 100 days. The company's market cap stands at $10.0 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kingstone Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KINS#NASDAQ">KINS</a>) stock fell 5.33% to $1.7 during Thursday's regular session. Trading volume for this security as of 13:40 EST is 6.5K, which is 28.4% of its average full-day volume over the last 100 days. The company's market cap stands at $21.4 million. </li>
<li>Oscar Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) stock fell 4.51% to $4.76. As of 13:40 EST, Oscar Health's stock is trading at a volume of 648.7K, which is 42.6% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion. </li>
<li>Employers Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIG#NYSE">EIG</a>) shares fell 4.27% to $37.75. Employers Holdings's stock is trading at a volume of 65.1K shares as of 13:40 EST. This is 53.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li>Reliance Global Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) shares decreased by 4.01% to $1.44. As of 13:40 EST, this security is trading at a volume of 430 shares, making up 0.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.0 million. </li>
<li>AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) stock fell 3.76% to $50.47. AMERISAFE's stock is trading at a volume of 93.6K shares as of 13:40 EST. This is 114.2% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li>Citizens (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIA#NYSE">CIA</a>) stock decreased by 3.55% to $2.99. The current volume of 29.8K shares is 66.9% of Citizens's average full-day volume over the last 100 days (last updated at 13:40 EST). The company's market cap stands at $153.8 million. </li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GBLI

KINS

OSCR

RELI

Insurance Stocks Moving In Thursday's Intraday Session

AMERISAFE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>), a specialty provider of workers' compensation insurance focused on high-hazard industries, today announced that its Board of Directors had declared a special cash dividend of $3.50 per share.
The special cash dividend will be payable on December 15, 2023 to shareholders of record as of December 1, 2023. The Board of Directors also declared a regular quarterly dividend of $0.34 per share, payable on December 15, 2023 to shareholders of record as of December 1, 2023.
"We are pleased to announce this special dividend which reflects our underwriting expertise and discipline. Returning excess capital to shareholders via special dividends is a key component of AMERISAFE's capital management strategy," said G. Janelle Frost, President and Chief Executive Officer.
Over the past eleven years, the Company has declared $42.89 per share in dividends, comprising $9.64 in regular dividends and $33.25 in special dividends per share.
More information on the dividend and information on the company's third quarter earnings can be found in AMERISAFE's accompanying earnings release issued today.

AMERISAFE Declares Special Dividend Of $3.50 Per Share And Regular Quarterly Dividend Of $0.34 Per Share

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) reported quarterly earnings of $0.61 per share which missed the analyst consensus estimate of $0.69 by 11.59 percent. This is a 16.44 percent decrease over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $72.64 million which missed the analyst consensus estimate of $74.44 million by 2.42 percent. This is a 1.77 percent increase over sales of $71.38 million the same period last year.

AMERISAFE Q3 Adj EPS $0.61 Misses $0.69 Estimate, Sales $72.64M Miss $74.44M Estimate

AMERISAFE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSF#NASDAQ">AMSF</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.72 by 1.39 percent. This is a 7.35 percent increase over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $75.66 million which missed the analyst consensus estimate of $76.20 million by 0.71 percent. This is a 11.20 percent increase over sales of $68.04 million the same period last year.

AMERISAFE Q2 Adj EPS $0.73 Beats $0.72 Estimate, Sales $75.66M Miss $76.20M Estimate

AMERISAFE Q2 EPS $0.73 Beats $0.72 Estimate, Sales $75.66M Miss $76.20M Estimate

The most overbought stocks in the financial sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70.</a>
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Oportun Financial Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oprt#NASDAQ">OPRT</a>)</h3>
<ul>
<li>Oportun Financial posted a wider-than-expected Q1 loss. &quot;Our first quarter results reflect the continuation of our successful efforts to fortify our business economics, streamline operations and grow member engagement&quot;, said Raul Vazquez, CEO of Oportun. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/OPRT">52-week high of $12.79 </a>.</li>
<li>RSI Value: 73.21</li>
<li>OPRT Price Action: Shares of Oportun Financial rose 7.5% to close at $4.32 on Monday.</li>
</ul>
<h3>Lemonade, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lmnd#NYSE">LMND</a>)</h3>
<ul>
<li>Lemonade posted better-than-expected quarterly results. The company&rsquo;s <a href="https://www.benzinga.com/quote/LMND"> stock has a 52-week high </a> of $32.97.</li>
<li>RSI Value: 75.32</li>
<li>LMND Price Action: Shares of Lemonade rose 11.1% to close at $16.26 on Monday.</li>
</ul>
<h3>AMERISAFE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsf#NASDAQ">AMSF</a>)</h3>
<ul>
<li>AMERISAFE posted upbeat quarterly results. G. Janelle Frost, President and Chief Executive Officer commented, &quot;AMERISAFE&rsquo;s first quarter results reflect the company&rsquo;s disciplined approach to risk selection and adequate pricing within the high-hazard workers&rsquo; compensation market.&quot; The company has a <a href="https://www.benzinga.com/quote/AMSF"> 52-week high </a> of $60.49.</li>
<li>RSI Value: 74.15</li>
<li>AMSF Price Action: Shares of AMERISAFE fell 0.6% to close at $56.22 on Monday.</li>
</ul>
<h3>Cantaloupe, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctlp#NASDAQ">CTLP</a>)</h3>
<ul>
<li>Cantaloupe reported better-than-expected Q3 EPS and sales results. &quot;We experienced strong financial results in Q3, with record revenue in transaction fees and subscription fees, which demonstrates progress on our strategic initiatives and the adoption of our new products,&quot; said Ravi Venkatesan, chief executive officer, Cantaloupe. The company&rsquo;s 52-week high is $7.05.</li>
<li>RSI Value: 76.43</li>
<li>CTLP Price Action: Shares of Cantaloupe fell 0.5% to close at $6.71 on Monday.</li>
</ul>
<h3>Arthur J. Gallagher &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ajg#NYSE">AJG</a>)</h3>
<ul>
<li>Arthur J. Gallagher &amp; Co. reported the acquisition of Woodland Hills, California-based Leavitt Insurance Services of Los Angeles. The company <a href="https://www.benzinga.com/quote/AJG"> has a 52-week high </a> of $215.71.</li>
<li>RSI Value: 70.01</li>
<li>AJG Price Action: Shares of Arthur J. Gallagher rose 0.7% to settle at $215.32 on Monday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/23/05/32280110/investor-optimism-improves-ahead-of-inflation-data"> Investor Optimism Improves Ahead Of Inflation Data </a>

Dividend Champion, Contender, And Challenger Highlights: Week Of June 16

Warning: AMSF is at high risk of performing badly

AMERISAFE Non-GAAP EPS of $0.58 misses by $0.04, revenue of $75.83M beats by $5.41M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
AMERISAFE (NASDAQ:<a href="https://investorplace.com/stock-quotes/amsf-stock-quote/">AMSF</a>) just reported results for the second quarter of 2024.<ul><li>AMERISAFE reported earnings per share of 58 cents. This was below the analyst estimate for EPS of 63 cents.</li><li>The company reported revenue of $75.83 million.</li><li>This was 2.20% better than the analyst estimate for revenue of $74.20 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/07/amsf-stock-earnings-amerisafe-for-q2-of-2024/">AMSF Stock Earnings: AMERISAFE Misses EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

AMSF Stock Earnings: AMERISAFE Misses EPS, Beats Revenue for Q2 2024

Matthew Carletti, an analyst from JMP Securities, reiterated the Buy rating on Amerisafe (AMSF – Research Report). The associated price target is $...

Amerisafe's Solid Growth and Positive Outlook Merit Buy Rating

In a report released today, Mark Hughes from Truist Financial maintained a Hold rating on Amerisafe (AMSF – Research Report). The company's shares ...

Amerisafe (AMSF) Receives a Rating Update from a Top Analyst

AMERISAFE declares $0.37 dividend

AMERISAFE, Inc. (AMSF) Q2 2024 Earnings Call Transcript

Dividend Champion, Contender, And Challenger Highlights: Week Of September 1

Dividend Champion, Contender, And Challenger Highlights: Week Of September 15

ALLE

AMCR

AMGN

APLO

AVGO

AVNT

BOTJ

BSVN

BWXT

CARR

CBSH

CCBG

CCOI

CHRW

CINF

CNOB

CTAS

CTVA

EBMT

EBTC

EQIX

EVRG

EXPO

FFNW

FITB

FRME

GAIN

GNTY

GOLF

HOMB

IIPR

INGR

JBSS

JJSF

JKHY

KLAC

LANC

LAND

LFUS

LOGI

LRCX

MAIN

MATX

MBWM

MCHP

MKTX

MNRO

MOFG

MSEX

MTRN

MUSA

NRIM

ODFL

OTEX

OTIS

PATK

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

AMERISAFE

News

Latest news for AMERISAFE (NASDAQ:AMSF) Stock

People Also Watch